Zdrowie i gospodarka · 01/09/2020

FDA Requests Public Comment on Proposed Collection of Information for Adverse Experience Reporting and General Records

The Food and Drug Administration is seeking public input on a proposed extension of its Adverse Experience Reporting System for licensed biological products and general records related to biological product manufacturing and distribution, as required by the Paperwork Reduction Act of 1995.